Precision Health Corp.
hybrid fundWebsite
Fund rating
0.0 / 35
0 published reviews
No per-dimension scores yet.
Published reviews
About
Explicitly invests in companies with disruptive technologies that improve longevity and quality of life. OpenDrugs fits the longevity and precision-health thesis through its evidence-backed compound database, pathway analysis, and AI-assisted research workflows.